Ocuphire Pharma Inc.

05/12/2021 | Press release | Distributed by Public on 05/12/2021 05:32

Ocuphire Completes Enrollment in VEGA-1 Phase 2 Clinical Trial Investigating Nyxol® in Combination with Low-Dose Pilocarpine for Treatment of Presbyopia